Rhode Island H7537 mandates insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss.

Rhode Island H7537 requires insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss. Scalp cooling systems are defined as medical devices approved by the U.S. Food and Drug Administration designed to cool the scalp to reduce chemotherapy-induced alopecia. This coverage applies to individual or group hospital or medical expense insurance policies and hospital or medical services plan contracts delivered, issued for delivery, or renewed in Rhode Island on or after January 1, 2027.

Rhode Island H7537 mandates insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss.

Rhode Island H7537 requires insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss. Scalp cooling systems are defined as medical devices approved by the U.S. Food and Drug Administration designed to cool the scalp to reduce chemotherapy-induced alopecia. This coverage applies to individual or group hospital or medical expense insurance policies and hospital or medical services plan contracts delivered, issued for delivery, or renewed in Rhode Island on or after January 1, 2027.